Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(3.81)
# 695
Out of 5,050 analysts
387
Total ratings
42.93%
Success rate
10.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $31.20 | +60.26% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $4.11 | +191.97% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $442.70 | +28.76% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $5.45 | +633.94% | 17 | Aug 4, 2025 | |
| ATAI Atai Beckley | Maintains: Buy | $10 → $15 | $4.36 | +244.04% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $11.55 | -13.42% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $1.59 | +215.46% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.47 | +2,019.54% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $6.58 | +1,039.82% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $33.50 | +198.51% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $27.79 | +151.89% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.02 | +390.20% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $6.14 | +877.20% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $39.23 | +103.93% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $13.50 | +196.30% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.23 | +609.22% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $31.43 | +122.72% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $22.21 | +260.20% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.71 | +484.80% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.36 | +323.73% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $11.70 | +370.09% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $5.13 | +2,044.25% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $58.79 | +44.58% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $5.98 | +2,408.36% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $12.79 | +431.67% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $189.59 | +79.33% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $31.20
Upside: +60.26%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $4.11
Upside: +191.97%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $442.70
Upside: +28.76%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $5.45
Upside: +633.94%
Atai Beckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $4.36
Upside: +244.04%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $11.55
Upside: -13.42%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.59
Upside: +215.46%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.47
Upside: +2,019.54%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $6.58
Upside: +1,039.82%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $33.50
Upside: +198.51%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $27.79
Upside: +151.89%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.02
Upside: +390.20%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $6.14
Upside: +877.20%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $39.23
Upside: +103.93%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $13.50
Upside: +196.30%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $4.23
Upside: +609.22%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $31.43
Upside: +122.72%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $22.21
Upside: +260.20%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.71
Upside: +484.80%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $2.36
Upside: +323.73%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $11.70
Upside: +370.09%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $5.13
Upside: +2,044.25%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $58.79
Upside: +44.58%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $5.98
Upside: +2,408.36%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $12.79
Upside: +431.67%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $189.59
Upside: +79.33%